These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4386133)

  • 41. [Effect of anaprilin on hemodynamics and cardiac rhythm].
    Zharko KP
    Vrach Delo; 1971 Jul; 7():33-6. PubMed ID: 4399348
    [No Abstract]   [Full Text] [Related]  

  • 42. [Beta adrenergic blocking agents in Chagasic heart disease].
    Plotquin Y; Abrahim HC
    Prensa Med Argent; 1968 Oct; 55(35):1725-30. PubMed ID: 4977209
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of heart arrhythmias with a beta adrenergic blocking agent: Ciba 39,089 Ba].
    Maranhão MF; Lacerda FS; de Cicco LA; Cunha GP
    Arq Bras Cardiol; 1970 Oct; 23(5):327-34. PubMed ID: 4396431
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparative study of dextro-alprenolol, dextro-propranolol and practolol in the treatment of ventricular ectopic beats.
    Smith E; Bennet D; Sowton E
    Guys Hosp Rep; 1971; 120(1):9-15. PubMed ID: 4397736
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical value of beta-adrenergic receptor blocking agents].
    Chmielewski T
    Wiad Lek; 1970 Aug; 23(15):1317-20. PubMed ID: 4917574
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical evaluation of various hemodynamic effects induced by adrenergic-beta block].
    Delgrossi S; Matteoli E
    Cuore Circ; 1968 Apr; 52(2):92-100. PubMed ID: 4245299
    [No Abstract]   [Full Text] [Related]  

  • 47. [Beta-receptor-blocking agents and their current clinical significance].
    Deptalla H; Wiegershausen B
    Dtsch Gesundheitsw; 1968 Dec; 23(50):2353-63. PubMed ID: 4389656
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical action of a new cardioactive glycoside: proscillaridin A].
    Facci M
    Minerva Med; 1967 Dec; 58(96):4276-86. PubMed ID: 6083289
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 50. [Some side-effects of bunaftine in direct venous administration].
    Veglia L; Basile F; Guerricchio G
    Boll Soc Ital Cardiol; 1975; 20(4):371-6. PubMed ID: 1231918
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical use of bunaftine in the therapy of arrhythmia in patients with decompensated heart disease].
    Pisano E; Sulcis A; Sanna M
    Minerva Cardioangiol; 1975 Dec; 23(12):937-40. PubMed ID: 1232590
    [No Abstract]   [Full Text] [Related]  

  • 52. [Rhythmic disorders due to digitalis overdose].
    Valère PE; Guérot C; Lancelin B; Tricot R
    Ann Med Interne (Paris); 1972 Mar; 123(3):199-211. PubMed ID: 4405466
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
    Mastandrea R; Malagnino G; Astorri E; Visoli O
    Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy with beta-receptor blocking agents in cardiology practice].
    Kluthe R; Müller H; Steim H
    Ther Ggw; 1970 Mar; 109(3):372 passim. PubMed ID: 5439772
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapeutic applications of an adrenergic beta-receptor-blocking agent, propranolol, in cardiology].
    Bory M; Poggi L; Serradimigni A; Audier M
    Coeur Med Interne; 1969 Apr; 8(2):273-83. PubMed ID: 5790784
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of beta adrenergic blockaders on repolarization phase abnormalities in electrocardiography of patients with organic heart disease].
    Wrabec K; Lukasik S; Nowosad H; Adamus J
    Pol Tyg Lek; 1974 Jul; 29(26):1109-11. PubMed ID: 4848571
    [No Abstract]   [Full Text] [Related]  

  • 58. [Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide].
    Botti G
    Boll Soc Ital Cardiol; 1972; 17(11):1089-104. PubMed ID: 4620064
    [No Abstract]   [Full Text] [Related]  

  • 59. [Preliminary clinical observations on the anti-arrhythmic action of a new beta-receptor blocking agent: propranolol].
    Cherchi A; Lixi M; Mazza B; Camoglio E
    Minerva Med; 1966 Jan; 57(9):317-27. PubMed ID: 5909139
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical use of beta adrenergic inhibiting agents in cardiovascular therapeutics].
    Scebat L
    Therapeutique; 1968 Nov; 44(9):560-4. PubMed ID: 4396094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.